Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
50 hedge funds and large institutions have $9.21M invested in Molecular Templates, Inc. in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 12 closing their positions.
14% less funds holding
Funds holding: 58 → 50 (-8)
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
61% less capital invested
Capital invested by funds: $23.4M → $9.21M (-$14.2M)
61% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 18
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$566K |
| 2 |
Millennium Management
New York
|
+$35.4K |
| 3 |
Jane Street
New York
|
+$28.8K |
| 4 |
HG
Herbst Group
Westport,
Connecticut
|
+$21.2K |
| 5 |
VF
Virtu Financial
New York
|
+$13.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$1.03M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$597K |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$396K |
| 4 |
BlackRock
New York
|
-$185K |
| 5 |
Renaissance Technologies
New York
|
-$131K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
51
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$19K | -1,778 | Closed |
|
52
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$20K | -1,738 | Closed |
|
53
Balyasny Asset Management
Chicago,
Illinois
| – | -$18K | -1,630 | Closed |
|
54
UBS Group
Zurich,
Switzerland
| – | -$12K | -1,031 | Closed |
|
|
LP
55
LMR Partners
London,
United Kingdom
| – | -$10K | -879 | Closed |
|
56
JP Morgan Chase
New York
| – | -$1.26K | -152 | -79% |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$25 | -3 | -12% |
|
MTEM Hedge Fund Activity: Q4 2022 in Review
50 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2022, worth a combined $9.21M — down 61% from $23.4M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of MTEM and 5 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 7 added.
The largest buyer was Credit Suisse, opening a new position worth an estimated $566K. The largest seller was Frazier Life Sciences Management, exiting entirely with an estimated $1.03M sold.
- 50 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2022, down from 58 in Q3 2022.
- Funds reported $9.21M of Molecular Templates, Inc. stock for Q4 2022, down 61% quarter-over-quarter.
- 5 funds opened new Molecular Templates, Inc. positions in Q4 2022 and 12 closed out, a net change of -7 holders.
- The largest Molecular Templates, Inc. buyer in Q4 2022 was Credit Suisse, an estimated $566K added.
- The largest Molecular Templates, Inc. seller in Q4 2022 was Frazier Life Sciences Management, an estimated $1.03M sold.
Based on aggregated 13F filings for Q4 2022.